Alan Quatermain

The Tumblog of one Jim Dovey, iOS Software Chief Architect at Kobo in Toronto, Ontario.
He Twitters, he has an , and can occasionally be found on LinkedIn or Facebook.
If you have a query, you can ask it here.

This blog contains personal opinions, and is not endorsed by any company.

106978517
Myriad’s monopoly on the BRCA genes makes it impossible for women to use other tests or get a second opinion about their results, and allows Myriad to charge a high rate for their tests – over $3,000, which is too expensive for some women to afford.

PUBPAT > Breast Cancer Gene Patents

I have a number of close relatives who’ve had breast cancer. On more than one occasion, in fact. Money-grabbing twats like this are half the reason these things recur.